Angelika Amon wins 2019 Breakthrough Prize in Life Sciences
Four other MIT researchers to receive New Horizons Prizes in math and physics; two alumni win Breakthrough Prize in Fundamental Physics.
Four other MIT researchers to receive New Horizons Prizes in math and physics; two alumni win Breakthrough Prize in Fundamental Physics.
Biological engineers design RNA circuits that enable precise control over the dose of therapeutic protein a patient receives.
New approach generates a wider variety of protein sequences optimized to bind to drug targets.
New MIT initiative delves into the biology of stem cells and cancer stem cells, seeks ways to identify, purify, and propagate them.
Lustgarten Foundation names MIT laboratory to improve understanding and treatment of a deadly disease
Natural killer cells’ failure to respond to infection may explain why the disease is more grave in some patients.
System can be rapidly reconfigured to produce a variety of protein drugs.
Three MIT postdocs earn competitive Howard Hughes Medical Institute fellowships that support diversity in the sciences.
Tiny probes could be useful for monitoring patients with Parkinson’s and other diseases.
Matthew Vander Heiden seeks new cancer treatments that exploit tumor cells’ abnormal metabolism.
Biologists discover that the environment surrounding a cell plays an integral role in its ability to accurately segregate its chromosomes.
Findings suggest mechanisms for the persistence of nasal polyps and possible new treatment strategies.
The new Convergence Scholars Program bridges disciplines and helps young researchers further their skills and build their brands as scientists.
Unexpected findings show that the body’s own immune system destroys retinal cells.
With new method, surgeons would remove tumor, then implant microparticles that attack remaining cancer cells.